Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Hepatology

• Publication date

  1999-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0168-8278(99)80169-XPMID 10424289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distribution of Ito cells in experimental hepatic fibrosis.

  2008cited by this paper
• Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells.

  1997cited by this paper
• Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes.

  1997cited by this paper
• Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor β in a bile duct ligated rat model of cirrhosis

  1997cited by this paper
• On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis.

  1996cited by this paper
• Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.

  1996cited by this paper
• Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis.

  1996cited by this paper
• Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion.

  1996cited by this paper
• Transforming growth factor‐β1 regulates platelet‐derived growth factor receptor β subunit in human liver fat‐storing cells

  1995cited by this paper
• Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells.

  1995cited by this paper
• Growth factor and procollagen type I gene expression in human liver disease.

  1995cited by this paper
• Expression of platelet‐derived growth factor in a model of acute liver injury

  1994cited by this paper
• Platelet-derived growth factor receptor signals.

  1994cited by this paper
• Transforming growth factor‐β1 and mannose 6‐phosphate/insulin‐like growth factor‐II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat

  1994cited by this paper
• Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture.

  1994cited by this paper
• Undulin RNA and protein expression in normal and fibrotic human liver

  1994cited by this paper
• Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells.

  1994cited by this paper
• EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR RECEPTORS IN NORMAL AND DISEASED HUMAN KIDNEY

  1994cited by this paper
• Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study.

  1994cited by this paper
• Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis.

  1994cited by this paper
• Differing signal transductions elicited by three isoforms of platelet-derived growth factor in vascular smooth muscle cells.

  1993cited by this paper
• Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells.

  1993cited by this paper
• In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury.

  1993cited by this paper
• Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions.

  1993cited by this paper
• Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors.

  1992cited by this paper
• PDGF alpha‐ and beta‐receptors activate unique and common signal transduction pathways.

  1992cited by this paper
• Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization.

  1991cited by this paper
• Characterization of platelet-derived growth factor beta-receptor expressing cells in the vasculature of human rheumatoid synovium.

  1991cited by this paper
• Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease.

  1991cited by this paper
• Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis.

  1991cited by this paper
• Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells.

  1991cited by this paper
• Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo.

  1990cited by this paper
• Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis.

  1990cited by this paper
• Expression of the gene of the α-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells

  1990cited by this paper
• Localization of PDGF-B protein in macrophages in all phases of atherogenesis.

  1990cited by this paper
• Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis.

  1990cited by this paper
• Platelet-derived growth factor.

  1989cited by this paper
• Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma.

  1989cited by this paper
• Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix.

  1989cited by this paper
• Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver.

  1989cited by this paper
• Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens.

  1989cited by this paper
• Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.

  1989cited by this paper
• cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor.

  1989cited by this paper
• Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

  1989cited by this paper
• Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells.

  1989cited by this paper
• Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes.

  1989cited by this paper
• Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta.

  1989cited by this paper
• PLATELET-DERIVED GROWTH FACTOR

  1989cited by this paper
• Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules.

  1988cited by this paper
• cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules

  1988cited by this paper
• Two classes of PDGF receptor recognize different isoforms of PDGF.

  1988cited by this paper
• Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization.

  1988cited by this paper
• Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• The biology of platelet-derived growth factor

  1986cited by this paper
• A significant part of macrophage-derived growth factor consists of at least two forms of PDGF.

  1985cited by this paper
• Transformation of NIH 3T3 cells by a human c-sis cDNA clone

  1984cited by this paper
• Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat.

  1984cited by this paper
• HISTOCHEMICAL AND ULTRASTRUCTURAL DEMONSTRATION OF γ-GLUTAMYL TRANSPEPTIDASE ACTIVITY

  1969cited by this paper
• Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity.

  1969cited by this paper

• Microenvironmental control of the ductular reaction: balancing repair and disease progression

  2025cites this paper
• Ultrasound‐Mediated Biomimetic Microbubbles Effectively Reverse LSECs Capillarization and Exert Antiplatelet Therapy in Liver Fibrosis

  2025cites this paper
• Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics

  2025cites this paper
• Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted

  2023cites this paper
• Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

  2023cites this paper
• Cholangiokines: undervalued modulators in the hepatic microenvironment

  2023cites this paper
• Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity

  2023cites this paper
• Identification of the Tumor Boundary of Hilar Cholangiocarcinoma Based on Multiphoton Microscopy

  2022cites this paper
• Immunopathogenesis of Liver Cirrhosis

  2020cites this paper
• Intrahepatische Gallenwegserkrankungen

  2020cites this paper
• SOX9 in biliary atresia: New insight for fibrosis progression.

  2020cites this paper
• PDGFA gene rs9690350 polymorphism increases biliary atresia risk in Chinese children

  2020cites this paper
• Définir de nouvelles cibles thérapeutiques pour l´hépatite alcoolique : nécessité d´une approche translationnelle

  2019cites this paper
• 2.16 – Mechanisms of Liver Fibrosis☆

  2018cites this paper
• The balancing act of the liver: tissue regeneration versus fibrosis

  2018influential citation
• HISTOPATHOLOGICAL ANALYSIS OF DUCTULAR REACTION IN RABBIT LIVER AFTER CHRONIC EXPOSURE OF CHROMIUM ( VI )

  2018cites this paper
• 9 – Bile Duct Diseases

  2018cites this paper
• Role of sirolimus in fibrogenesis inhibition in secondary biliary cirrhosis. Experimental model in rat

  2018cites this paper
• Immunology of Primary Sclerosing Cholangitis

  2017cites this paper
• Ultrastructural Characteristics of Rat Hepatic Oval Cells and Their Intercellular Contacts in the Model of Biliary Fibrosis: New Insights into Experimental Liver Fibrogenesis

  2017cites this paper
• New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets.

  2017cites this paper
• Regulators of Cholangiocyte Proliferation.

  2017cites this paper
• EMERGING ROLES OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA IN CHRONIC LIVER INJURY: POTENTIAL THERAPEUTIC TARGET IN HEPATIC FIBROSIS

  2017cites this paper
• The PDGF system and its antagonists in liver fibrosis.

  2016cites this paper
• The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.

  2016cites this paper
• The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor‐β1 biliary secretion in mice

  2016cites this paper
• Benign Epithelial Tumors and Hamartomas of the Biliary Tract

  2016cites this paper
• Cirrhosis and autoimmune liver disease: Current understanding

  2016cites this paper
• Role of platelet-derived growth factor B in cholesterol and glucose metabolism

  2016cites this paper
• The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.

  2015cites this paper
• Original Article Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease

  2015cites this paper
• M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice

  2015cites this paper
• Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease.

  2015cites this paper
• PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer.

  2015cites this paper
• Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanisms.

  2015cites this paper
• Starring role of toll-like receptor-4 activation in the gut-liver axis.

  2015cites this paper
• 3. Stellate cells

  2015cites this paper
• Hepatic progenitor cells in children with chronic hepatitis C: correlation with histopathology, viremia, and treatment response

  2015cites this paper
• Pulmonary, gastrointestinal and urogenital pharmacologyCilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats

  2015cites this paper
• Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation

  2015cites this paper
• Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts

  2015cites this paper
• PDGF-Mediated Regulation of Liver Fibrosis

  2015cites this paper
• Osteopontin induces ductular reaction contributing to liver fibrosis

  2014cites this paper
• Anatomy and Physiology of the Biliary Epithelium

  2014cites this paper
• Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.

  2014cites this paper
• Beneficial effects of platelet-derived growth factor on hemorrhagic shock in rats and the underlying mechanisms.

  2014cites this paper
• Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.

  2014cites this paper
• Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition.

  2014cites this paper
• Liver cell types derived from pluripotent stem cells

  2014cites this paper
• Vascular biology of the biliary epithelium

  2013cites this paper
• Principles of liver regeneration and growth homeostasis.

  2013cites this paper
• Role of Hepatic Progenitor Cells in Nonalcoholic Fatty Liver Disease Development: Cellular Cross-Talks and Molecular Networks

  2013cites this paper
• Autocrine regulation of biliary pathology by activated cholangiocytes.

  2012influential citation
• Lipopolysaccharide enhances transforming growth factor β1‐induced platelet‐derived growth factor‐B expression in bile duct epithelial cells

  2012cites this paper
• Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease

  2012cites this paper
• The Crucial Role of Cholangiocytes in Cholangiopathies

  2012influential citation
• Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus

  2012cites this paper
• 10 – Diseases of the bile ducts

  2012cites this paper
• Lipopolysaccharide enhances transforming growth factor β 1-induced PDGF-B expression in bile duct epithelial cells

  2012cites this paper
• Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent.

  2012cites this paper
• Role of epithelial to mesenchymal transition in genetic cholangiopathies related to fibrocystin deficiency

  2011cites this paper
• Biliary Epithelial Cells

  2011cites this paper
• Fibrosis in Autoimmune and Cholestatic Liver Disease

  2011cites this paper
• Epithelial–Mesenchymal Interactions in Biliary Diseases

  2011cites this paper
• Paracrine modulation of cholangiocyte serotonin synthesis orchestrates biliary remodeling in adults.

  2011cites this paper
• Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?

  2011cites this paper
• Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver desease

  2011cites this paper
• Antifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats.

  2010cites this paper
• Involvement of cholangiocyte proliferation in biliary fibrosis.

  2010cites this paper
• Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development

  2010cites this paper
• Sonic Hedgehog Pathway

  2010cites this paper
• Mechanisms of Liver Fibrosis

  2010cites this paper
• Anatomy and Physiology of the Biliary Epithelium

  2010cites this paper
• Effects of lipopolysaccharide on platelet‐derived growth factor isoform and receptor expression in cultured rat common bile duct fibroblasts and cholangiocytes

  2009cites this paper
• Genetic and molecular abnormalities in cholangiocarcinogenesis.

  2009cites this paper
• Cholangiocyte proliferation and liver fibrosis

  2009cites this paper
• Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.

  2008cites this paper
• Inflammation and Repair in Viral Hepatitis C

  2008cites this paper
• Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell‐to‐cell interaction and transition

  2008cites this paper
• Oxidative a nd Nitrosative Stress a nd Fibrogenic Response

  2008cites this paper
• Identification of the role of angiotensin and angiotensin blockade in hepatic fibrosis of bile-duct ligation model

  2008cites this paper
• Oxidative and nitrosative stress and fibrogenic response.

  2008cites this paper
• Redox mechanisms in hepatic chronic wound healing and fibrogenesis

  2008cites this paper
• The hedgehog pathway regulates remodelling responses to biliary obstruction in rats

  2008cites this paper
• ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells.

  2008cites this paper
• Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation

  2007cites this paper
• Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others.

  2007cites this paper
• Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

  2007cites this paper
• Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro.

  2007cites this paper
• Cholangiocyte Injury and Ductopenic Syndromes

  2007cites this paper
• Molecular pathology of biliary tract cancers.

  2007cites this paper
• Cholangiocyte injury and ductopenic syndromes.

  2007cites this paper
• Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver.

  2007cites this paper
• Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations

  2007cites this paper
• Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term.

  2006cites this paper
• Etiopathogenesis of Primary Sclerosing Cholangitis

  2006cites this paper
• Bile acid interactions with cholangiocytes.

  2006cites this paper
• Etiopathogenesis of primary sclerosing cholangitis.

  2006cites this paper
• Platelet-Derived Growth Factor Gene Polymorphism in Recurrent Hepatitis C Infection after Liver Transplantation

  2006cites this paper
• Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices

  2006cites this paper